Work

Use of Bone Marrow Stromal Cell-derived Fate-committed Glial Precursors for Remyelination Therapy

Year: 2023
Type: article
Abstract: Donor nerve-derived Schwann cells transplanted to the severed nerve/tract in the PNS/CNS improves prospects of post-traumatic recovery in rat models. Clinical translation however requires sufficient quantities of immuno-compatible and fate-committed glial precursors. Following pilot studies with rat cells, we enriched the neuroprogenitor subpopulation among human bone marrow (hBM) stromal cells in culture and then with selected glia-inducing supplements, yielded either Schwann cell-like cells (SCLCs) or oligodendrocyte precursors (OPs).
Language: English
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W4388364247
FWCI:
Cites:
Cited by:
Related to: 10